Anterix Analyst Price Targets - Benzinga

Anterix Inc

ATEXNASDAQ

Trade with Public

Trade with Public

$81.80

0.050.06%

Últ. Act.: Sep 29, 8:45 AM

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Comparar Opciones Informe de acciones

Anterix Analyst Price Targets

Wall Street analyst price targets and consensus rating for Anterix (ATEX).

Price Target Range — 6 Quarters

Analyst Consensus — 2 Analysts

1Buy

1Hold

Consensus RatingOverweight# Analysts2Avg. Consensus PT$82Upside to Avg. PT-0.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 13, 2026	JP Morgan	Sebastiano Petti	PT Cut	Overweight	$133→$130
Jul 20, 2026	JP Morgan	Sebastiano Petti	PT Raise	Overweight	$50→$133
Jun 4, 2026	B. Riley Securities	Mike Crawford	Downgrade	Buy→Neutral	$44→$69
Oct 17, 2025	JP Morgan	Sebastiano Petti	PT Cut	Overweight	$67→$50
Feb 13, 2025	JP Morgan	Jerome Darling	PT Raise	Overweight	$61→$67
Aug 8, 2024	JP Morgan	Philip Cusick	PT Raise	Overweight	$60→$61
Feb 16, 2024	B. Riley Securities	Mike Crawford	Maintained	Buy	$75

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
JP Morgan Maintains Overweight on Anterix, Lowers Price Target to $130

JP Morgan analyst Sebastiano Petti maintains Anterix (NASDAQ:ATEX) with a Overweight and lowers the price target from $133 to $130.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Anterix, Raises Price Target to $133

JP Morgan analyst Sebastiano Petti maintains Anterix (NASDAQ:ATEX) with a Overweight and raises the price target from $50 to $133.

Benzinga Newsdesk

PRO
B. Riley Securities Downgrades Anterix to Neutral, Raises Price Target to $69

B. Riley Securities analyst Mike Crawford downgrades Anterix (NASDAQ:ATEX) from Buy to Neutral and raises the price target from $44 to $69.

Benzinga Newsdesk

PRO
Watching Anterix; Shares See Volume To The Upside, Hearing Zacks Home Run Investor Newsletter Mentions Stock As A Buy

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Anterix, Raises Price Target to $67

JP Morgan analyst Jerome Darling maintains Anterix (NASDAQ:ATEX) with a Overweight and raises the price target from $61 to $67.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Anterix, Raises Price Target to $61

JP Morgan analyst Philip Cusick maintains Anterix (NASDAQ:ATEX) with a Overweight and raises the price target from $60 to $61.

Benzinga Newsdesk